FURADANTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Furadantin, and when can generic versions of Furadantin launch?
Furadantin is a drug marketed by Casper Pharma Llc and Procter And Gamble and is included in two NDAs.
The generic ingredient in FURADANTIN is nitrofurantoin. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Furadantin
A generic version of FURADANTIN was approved as nitrofurantoin by IMPAX LABS INC on January 28th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FURADANTIN?
- What are the global sales for FURADANTIN?
- What is Average Wholesale Price for FURADANTIN?
Summary for FURADANTIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 2 |
| Patent Applications: | 6,113 |
| Drug Prices: | Drug price information for FURADANTIN |
| What excipients (inactive ingredients) are in FURADANTIN? | FURADANTIN excipients list |
| DailyMed Link: | FURADANTIN at DailyMed |
Recent Clinical Trials for FURADANTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Early Phase 1 |
| Ministero della Salute, Italy | Phase 3 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Phase 3 |
Pharmacology for FURADANTIN
| Drug Class | Nitrofuran Antibacterial |
US Patents and Regulatory Information for FURADANTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | FURADANTIN | nitrofurantoin | SUSPENSION;ORAL | 009175-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Procter And Gamble | FURADANTIN | nitrofurantoin | TABLET;ORAL | 008693-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Casper Pharma Llc | FURADANTIN | nitrofurantoin | SUSPENSION;ORAL | 009175-002 | Jun 9, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Procter And Gamble | FURADANTIN | nitrofurantoin | TABLET;ORAL | 008693-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
